Article info

Download PDFPDF
Doxapram for apnoea of prematurity and neurodevelopmental outcomes at age 5–6 years

Authors

  • Ludovic Tréluyer Sorbonne Paris-Nord, Inserm, INRAE, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, Université Paris Cité, Paris, France Department of Neonatal Medicine of Port-Royal, Cochin Hospital, FHU PREMA, AP-HP Centre–Université Paris Cité, Paris, France PubMed articlesGoogle scholar articles
  • Elodie Zana-Taieb Department of Neonatal Medicine of Port-Royal, Cochin Hospital, FHU PREMA, AP-HP Centre–Université Paris Cité, Paris, France Université Paris Cité, Inserm U955, Paris, France PubMed articlesGoogle scholar articles
  • Pierre-Henri Jarreau Sorbonne Paris-Nord, Inserm, INRAE, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, Université Paris Cité, Paris, France Department of Neonatal Medicine of Port-Royal, Cochin Hospital, FHU PREMA, AP-HP Centre–Université Paris Cité, Paris, France PubMed articlesGoogle scholar articles
  • Valérie Benhammou Sorbonne Paris-Nord, Inserm, INRAE, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, Université Paris Cité, Paris, France PubMed articlesGoogle scholar articles
  • Pierre Kuhn Department of Neonatal Medicine, University Hospital of Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  • Mathilde Letouzey Department of Neonatal Medicine, Poissy Saint-Germain Hospital, Poissy, France PubMed articlesGoogle scholar articles
  • Laetitia Marchand-Martin Sorbonne Paris-Nord, Inserm, INRAE, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, Université Paris Cité, Paris, France PubMed articlesGoogle scholar articles
  • Wes Onland Department of Neonatal Medicine, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands Amsterdam Reproduction and Development Research Institute, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Véronique Pierrat Sorbonne Paris-Nord, Inserm, INRAE, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, Université Paris Cité, Paris, France Department of Neonatology, CHI Créteil, Créteil, France PubMed articlesGoogle scholar articles
  • Lauren Saade Department of Neonatal Medicine of Port-Royal, Cochin Hospital, FHU PREMA, AP-HP Centre–Université Paris Cité, Paris, France PubMed articlesGoogle scholar articles
  • Pierre Yves Ancel Sorbonne Paris-Nord, Inserm, INRAE, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, Université Paris Cité, Paris, France Clinical Research Unit, Center for Clinical Investigation P1419, Assistance Publique-Hôpitaux de Paris, Paris, France PubMed articlesGoogle scholar articles
  • Héloïse Torchin Sorbonne Paris-Nord, Inserm, INRAE, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, Université Paris Cité, Paris, France Department of Neonatal Medicine of Port-Royal, Cochin Hospital, FHU PREMA, AP-HP Centre–Université Paris Cité, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ludovic Tréluyer, Sorbonne Paris-Nord, Inserm, INRAE, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, Université Paris Cité, Paris, 75010, France; ludovic.treluyer{at}inserm.fr
View Full Text

Citation

Tréluyer L, Zana-Taieb E, Jarreau P, et al
Doxapram for apnoea of prematurity and neurodevelopmental outcomes at age 5–6 years

Publication history

  • Received August 3, 2023
  • Accepted December 15, 2023
  • First published January 16, 2024.
Online issue publication 
June 19, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.